Concentra Group Holdings Hits New 52-Week High at $29.75

Concentra Group Holdings Parent, Inc. has reached a significant milestone by hitting a new 52-week high of USD 29.75 on June 25, 2026. This achievement marks a notable increase from its 52-week low of USD 18.55, showcasing the stock's upward trajectory over the past year. In terms of performance, Concentra Group Holdings has outperformed the S&P 500, with a one-year performance rate of 20.77%. The company operates within the Pharmaceuticals & Biotechnology sector and is classified as a small-cap entity, boasting a market capitalization of USD 2,717 million. Financial metrics indicate a price-to-earnings (P/E) ratio of 15.00, while the price-to-book ratio stands at 6.91. The company currently does not offer a dividend yield, and its debt-to-equity ratio is reported at 4.01. Despite a notably high return on equity figure, the context of this metric suggests further examination may be warranted. Overall, the recent price movement reflects a significant moment for Concentra Group Holdings in the competitive pharmaceutical landscape.